Protalix BioTherapeutics (PLX) EPS (Basic) (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protalix BioTherapeutics | 189.64 Mn | 178.85 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 604.69% |
| Dec 31, 2025 | -249.86% |
| Sep 30, 2025 | 506.38% |
| Jun 30, 2025 | 110.63% |
| Mar 31, 2025 | -131.71% |
| Dec 31, 2024 | 215.61% |
| Sep 30, 2024 | 257.09% |
| Jun 30, 2024 | 52.23% |
| Mar 31, 2024 | 78.89% |
| Dec 31, 2023 | -1,063.37% |
| Sep 30, 2023 | -110.62% |
| Jun 30, 2023 | 543.09% |
| Mar 31, 2023 | 17.75% |
| Dec 31, 2022 | 8.10% |
| Sep 30, 2022 | 36.06% |
| Jun 30, 2022 | -126.02% |
| Mar 31, 2022 | 62.23% |
| Dec 31, 2021 | -40.05% |
| Sep 30, 2021 | 62.32% |
| Jun 30, 2021 | -70.48% |